JPH0255407B2 - - Google Patents

Info

Publication number
JPH0255407B2
JPH0255407B2 JP55102315A JP10231580A JPH0255407B2 JP H0255407 B2 JPH0255407 B2 JP H0255407B2 JP 55102315 A JP55102315 A JP 55102315A JP 10231580 A JP10231580 A JP 10231580A JP H0255407 B2 JPH0255407 B2 JP H0255407B2
Authority
JP
Japan
Prior art keywords
placebo
days
treatment
medium
study
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55102315A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5622733A (en
Inventor
Fuarinu Jannkuroodo
Ribukinu Annu
Buruto Ishidoro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RABO OMU SA
Original Assignee
RABO OMU SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RABO OMU SA filed Critical RABO OMU SA
Publication of JPS5622733A publication Critical patent/JPS5622733A/ja
Publication of JPH0255407B2 publication Critical patent/JPH0255407B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10231580A 1979-07-26 1980-07-25 Immunity creature therapeutic drug and its manufacture Granted JPS5622733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH692479A CH639852A5 (fr) 1979-07-26 1979-07-26 Medicament contre les maladies infectieuses des voies urinaires et digestives.

Publications (2)

Publication Number Publication Date
JPS5622733A JPS5622733A (en) 1981-03-03
JPH0255407B2 true JPH0255407B2 (en:Method) 1990-11-27

Family

ID=4317195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10231580A Granted JPS5622733A (en) 1979-07-26 1980-07-25 Immunity creature therapeutic drug and its manufacture

Country Status (16)

Country Link
JP (1) JPS5622733A (en:Method)
AR (1) AR222887A1 (en:Method)
BE (1) BE884456A (en:Method)
CH (1) CH639852A5 (en:Method)
CS (1) CS212234B2 (en:Method)
DD (1) DD153192A5 (en:Method)
DE (1) DE3019448A1 (en:Method)
ES (1) ES8104402A1 (en:Method)
FR (1) FR2462164A1 (en:Method)
GB (1) GB2054374B (en:Method)
HU (1) HU181725B (en:Method)
IT (1) IT1143025B (en:Method)
PL (1) PL127520B1 (en:Method)
PT (1) PT71612A (en:Method)
RO (1) RO80054A (en:Method)
YU (1) YU42532B (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
EP2345421A1 (en) 2003-06-23 2011-07-20 Biotech Tools S.A. Epitope composition for sublingual or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
PL2117587T3 (pl) * 2007-03-05 2018-07-31 Om Pharma Ekstrakt bakteryjny przeznaczony do stosowania względem zaburzeń układu pokarmowego lub moczowego i sposób jego wytwarzania

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336015A (en) * 1970-06-03 1973-11-07 Unilever Ltd Rearing pigs
US3911109A (en) * 1971-10-14 1975-10-07 Lever Brothers Ltd Rearing calves
BE789864A (fr) * 1971-10-14 1973-04-09 Unilever Nv Elevage des veaux
JPS5219927B2 (en:Method) * 1972-06-08 1977-05-31
GB1462384A (en) * 1973-04-12 1977-01-26 Unilever Ltd Rearing of lambs
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
US4141970A (en) * 1975-05-07 1979-02-27 Internationale Octrooimaatschappij "Octropa" B.V. Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
US4136167A (en) * 1975-06-12 1979-01-23 Internationale Octrooi Maatschappij "Octropa" B.V. Process for reducing the incidence of neonatal diarrhoea in pigs
GB1581776A (en) * 1976-08-18 1980-12-17 Smith Kline Rit Vaccines against oedema disease of piglets

Also Published As

Publication number Publication date
IT8049314A0 (it) 1980-07-24
DD153192A5 (de) 1981-12-30
FR2462164A1 (fr) 1981-02-13
GB2054374A (en) 1981-02-18
DE3019448A1 (de) 1981-02-12
RO80054A (ro) 1982-10-26
JPS5622733A (en) 1981-03-03
HU181725B (en) 1983-11-28
ES491920A0 (es) 1981-04-01
PL127520B1 (en) 1983-11-30
DE3019448C2 (en:Method) 1987-07-30
AR222887A1 (es) 1981-06-30
IT1143025B (it) 1986-10-22
BE884456A (fr) 1980-11-17
FR2462164B1 (en:Method) 1983-08-05
ES8104402A1 (es) 1981-04-01
CS212234B2 (en) 1982-03-26
PL225853A1 (en:Method) 1981-05-08
GB2054374B (en) 1983-06-22
PT71612A (fr) 1980-08-01
CH639852A5 (fr) 1983-12-15
YU42532B (en) 1988-10-31
YU189680A (en) 1983-06-30

Similar Documents

Publication Publication Date Title
Kirkpatrick et al. Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution
KR0169982B1 (ko) 피부염 치료용 약제
SU1722502A1 (ru) Препарат биоспорин дл профилактики и лечени желудочно-кишечных заболеваний человека
Rasmussen et al. “Covert toxocariasis” in a child treated with low‐dose diethylcarbamazine
AU2022203621B2 (en) Use of cyanobacterial biomass in treating hepatitis b virus infection
PL126416B1 (en) Method of obtaining immunobiotherapeutic preparation counteractive against respiratory system diseases
JP3665850B2 (ja) 免疫賦活剤
KR20030069910A (ko) 암치료제
GB2077101A (en) Antiallergic composition containing streptococci
Hedgecock The effect of diet on the inducement of acquired resistance by viable and nonviable vaccines in experimental tuberculosis
CS212234B2 (en) Method of making the immunotherapeutical means against the infection decease uf urine and digesting ways
RU2203076C1 (ru) Способ лечения и профилактики желудочно-кишечных болезней телят
US4534966A (en) Composition for treating infectious diseases, gout or arteriosclerosis containing human pepsin and/or human leukocyte pepsin-like enzyme and method for using same
RU2101020C1 (ru) Препарат, обладающий иммуностимулирующим действием
JP2000290194A (ja) 病原性細菌およびウイルス感染防御剤
RU2790970C1 (ru) Способ иммуномодуляции у детей при бронхиальной астме или обменных нарушениях при заболеваниях почек
WO1997045530A1 (en) Use of streptococcus faecium strains and composition containing the same
Kuvibidila et al. Mitogenic response of lymph nodes and spleen lymphocytes from mice with moderate and severe iron deficiency anemia
JP2003088335A (ja) 排尿機能改善用食品組成物及びそれを含有する飲食品
RU2043106C1 (ru) Способ лечения острых кишечных инфекций у детей
JP2004256478A (ja) 免疫グロブリンａ抗体産生促進剤
Rockwell et al. Further studies on oral immunization to colds
JPH02174718A (ja) 免疫賦活剤
JP2024167772A (ja) 免疫賦活用組成物及び発現誘導用組成物
Naveh et al. Combined rifampicin and chloramphenicol therapy for Enterobacter osteomyelitis